KU Leuven presents the Leuven Brain Institute KU Leuven presents the Leuven Brain Institute KU Leuven has officially launched the Leuven Brain Institute (LBI). The institute is a new meeting place for brain researchers from all over the university. The goal is to boost knowledge about the nervous system through new collaborations. 31 May 2018 News
Practice makes perfect: The human brain can reprogram itself to control prosthetic limbs Practice makes perfect: The human brain can reprogram itself to control prosthetic limbs New research confirms that repeated use of an artificial limb leads the brain to rewire itself 05 Apr 2018 More news about ERC
Iceland gives £10m to build new dementia research facility at UCL Iceland gives £10m to build new dementia research facility at UCL 05 Apr 2018 Health
Health bodies warn of Brexit risk to medical research Health bodies warn of Brexit risk to medical research Brexit Health Alliance says a no deal Brexit threatens access to Europe-wide trials of new drugs 01 Mar 2018 News
Improving the manufacture of new medicines: apply for funding Organisations can apply for a share of up to £10 million to support the development of novel medicines, under the Industrial Strategy Challenge Fund. 22 Feb 2018 Health
Research points to lack of evidence that wearable biosensors improve patient outcomes Research points to lack of evidence that wearable biosensors improve patient outcomes A literature review indicates remote patient monitoring via biosensors is yet to demonstrate a positive impact on health 22 Jan 2018 Health
Stem cell researchers develop new method to study neurodegenerative diseases in the lab Stem cell researchers develop new method to study neurodegenerative diseases in the lab 18 Jan 2018 News
Proteomics analyses could present new opportunities to diagnose and treat dementias Proteomics analyses could present new opportunities to diagnose and treat dementias 11 Jan 2018 Health
VIB, CD3 and Galapagos NV enter license deal for the development of MALT1 inhibitors VIB, CD3 and Galapagos NV enter license deal for the development of MALT1 inhibitors 10 Jan 2018 Health